Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1110 | 2847 | 33.2 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
301 | 2 | THYROID CANCER//THYROID NODULE//PAPILLARY THYROID CARCINOMA | 18583 |
1110 | 1 | MEDULLARY THYROID CARCINOMA//RET PROTO ONCOGENE//MEDULLARY THYROID CANCER | 2847 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MEDULLARY THYROID CARCINOMA | authKW | 3364865 | 16% | 67% | 466 |
2 | RET PROTO ONCOGENE | authKW | 1499027 | 7% | 72% | 195 |
3 | MEDULLARY THYROID CANCER | authKW | 914965 | 5% | 59% | 144 |
4 | RET | authKW | 619132 | 7% | 30% | 190 |
5 | MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 | authKW | 483624 | 2% | 72% | 63 |
6 | MEN 2A | authKW | 467048 | 2% | 78% | 56 |
7 | MULTIPLE ENDOCRINE NEOPLASIA | authKW | 382369 | 4% | 34% | 106 |
8 | C CELL HYPERPLASIA | authKW | 343140 | 1% | 80% | 40 |
9 | RET MUTATION | authKW | 332755 | 1% | 97% | 32 |
10 | CALCITONIN | authKW | 311456 | 7% | 15% | 199 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 12764 | 26% | 0% | 750 |
2 | Oncology | 4148 | 21% | 0% | 603 |
3 | Pathology | 2504 | 9% | 0% | 255 |
4 | Surgery | 1739 | 15% | 0% | 429 |
5 | Genetics & Heredity | 1085 | 9% | 0% | 268 |
6 | Medicine, General & Internal | 1003 | 10% | 0% | 290 |
7 | Medical Laboratory Technology | 555 | 3% | 0% | 73 |
8 | Cell Biology | 294 | 7% | 0% | 207 |
9 | Radiology, Nuclear Medicine & Medical Imaging | 231 | 5% | 0% | 136 |
10 | Otorhinolaryngology | 133 | 2% | 0% | 53 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GEN VISCERAL VASC SURG | 58139 | 2% | 11% | 51 |
2 | CHARLIE HAYS CANC | 42894 | 0% | 100% | 4 |
3 | ONCOL UROL SURG | 42894 | 0% | 100% | 4 |
4 | PLA HOSP 117 | 42894 | 0% | 100% | 4 |
5 | HIGH TECHNOL STUDY ENVIRONM DAMAGE ENDOCRINE | 33396 | 0% | 35% | 9 |
6 | MOL TRANSLAT ENDOCRINOL | 31186 | 0% | 36% | 8 |
7 | AMBISEN | 28968 | 0% | 27% | 10 |
8 | SECT ENDOCRINOL DIABETOL | 25425 | 0% | 22% | 11 |
9 | UMR 5641 | 24500 | 0% | 29% | 8 |
10 | HUMAN CANC GENET GRP | 22291 | 1% | 13% | 16 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THYROID | 26200 | 3% | 3% | 95 |
2 | ENDOCRINE PATHOLOGY | 13760 | 1% | 4% | 35 |
3 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 9741 | 5% | 1% | 148 |
4 | ENDOCRINE-RELATED CANCER | 8348 | 1% | 2% | 36 |
5 | SURGERY | 6629 | 3% | 1% | 79 |
6 | CLINICAL ENDOCRINOLOGY | 6523 | 2% | 1% | 68 |
7 | ANNALES D ENDOCRINOLOGIE | 5992 | 1% | 2% | 34 |
8 | ONCOGENE | 4166 | 3% | 0% | 85 |
9 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 4126 | 2% | 1% | 45 |
10 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 3081 | 1% | 1% | 38 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEDULLARY THYROID CARCINOMA | 3364865 | 16% | 67% | 466 | Search MEDULLARY+THYROID+CARCINOMA | Search MEDULLARY+THYROID+CARCINOMA |
2 | RET PROTO ONCOGENE | 1499027 | 7% | 72% | 195 | Search RET+PROTO+ONCOGENE | Search RET+PROTO+ONCOGENE |
3 | MEDULLARY THYROID CANCER | 914965 | 5% | 59% | 144 | Search MEDULLARY+THYROID+CANCER | Search MEDULLARY+THYROID+CANCER |
4 | RET | 619132 | 7% | 30% | 190 | Search RET | Search RET |
5 | MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 | 483624 | 2% | 72% | 63 | Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2 | Search MULTIPLE+ENDOCRINE+NEOPLASIA+TYPE+2 |
6 | MEN 2A | 467048 | 2% | 78% | 56 | Search MEN+2A | Search MEN+2A |
7 | MULTIPLE ENDOCRINE NEOPLASIA | 382369 | 4% | 34% | 106 | Search MULTIPLE+ENDOCRINE+NEOPLASIA | Search MULTIPLE+ENDOCRINE+NEOPLASIA |
8 | C CELL HYPERPLASIA | 343140 | 1% | 80% | 40 | Search C+CELL+HYPERPLASIA | Search C+CELL+HYPERPLASIA |
9 | RET MUTATION | 332755 | 1% | 97% | 32 | Search RET+MUTATION | Search RET+MUTATION |
10 | CALCITONIN | 311456 | 7% | 15% | 199 | Search CALCITONIN | Search CALCITONIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WELLS, SA , ASA, SL , DRALLE, H , ELISEI, R , EVANS, DB , GAGEL, RF , LEE, N , MACHENS, A , MOLEY, JF , PACINI, F , ET AL (2015) REVISED AMERICAN THYROID ASSOCIATION GUIDELINES FOR THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA.THYROID. VOL. 25. ISSUE 6. P. 567 -610 | 226 | 74% | 96 |
2 | KLOOS, RT , ENG, C , EVANS, DB , FRANCIS, GL , GAGEL, RF , GHARIB, H , MOLEY, JF , PACINI, F , RINGEL, MD , SCHLUMBERGER, M , ET AL (2009) MEDULLARY THYROID CANCER: MANAGEMENT GUIDELINES OF THE AMERICAN THYROID ASSOCIATION.THYROID. VOL. 19. ISSUE 6. P. 565 -612 | 246 | 75% | 474 |
3 | WELLS, SA , PACINI, F , ROBINSON, BG , SANTORO, M , (2013) MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 AND FAMILIAL MEDULLARY THYROID CARCINOMA: AN UPDATE.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 98. ISSUE 8. P. 3149 -3164 | 109 | 77% | 62 |
4 | MAIA, AL , SIQUEIRA, DR , KULCSAR, MAV , TINCANI, AJ , MAZETO, GMFS , MACIEL, LMZ , (2014) DIAGNOSIS, TREATMENT, AND FOLLOW-UP OF MEDULLARY THYROID CARCINOMA: RECOMMENDATIONS BY THE THYROID DEPARTMENT OF THE BRAZILIAN SOCIETY OF ENDOCRINOLOGY AND METABOLISM.ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA. VOL. 58. ISSUE 7. P. 667 -700 | 159 | 68% | 2 |
5 | DE GROOT, JWB , LINKS, TP , PLUKKER, JTM , LIPS, CJM , HOFSTRA, RMW , (2006) RET AS A DIAGNOSTIC AND THERAPEUTIC TARGET IN SPORADIC AND HEREDITARY ENDOCRINE TUMORS.ENDOCRINE REVIEWS. VOL. 27. ISSUE 5. P. 535 -560 | 167 | 59% | 156 |
6 | MUKHERJEE, S , ZAKALIK, D , (2011) RET CODON 804 MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA 2: GENOTYPE-PHENOTYPE CORRELATIONS AND IMPLICATIONS IN CLINICAL MANAGEMENT.CLINICAL GENETICS. VOL. 79. ISSUE 1. P. 1 -16 | 109 | 97% | 9 |
7 | FIGLIOLI, G , LANDI, S , ROMEI, C , ELISEI, R , GEMIGNANI, F , (2013) MEDULLARY THYROID CARCINOMA (MTC) AND RET PROTO-ONCOGENE: MUTATION SPECTRUM IN THE FAMILIAL CASES AND A META-ANALYSIS OF STUDIES ON THE SPORADIC FORM.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 752. ISSUE 1. P. 36 -44 | 88 | 94% | 22 |
8 | SAKORAFAS, GH , FRIESS, H , PEROS, G , (2008) THE GENETIC BASIS OF HEREDITARY MEDULLARY THYROID CANCER: CLINICAL IMPLICATIONS FOR THE SURGEON, WITH A PARTICULAR EMPHASIS ON THE ROLE OF PROPHYLACTIC THYROIDECTOMY.ENDOCRINE-RELATED CANCER. VOL. 15. ISSUE 4. P. 871 -884 | 103 | 95% | 20 |
9 | ARIGHI, E , BORRELLO, MG , SARIOLA, H , (2005) RET TYROSINE KINASE SIGNALING IN DEVELOPMENT AND CANCER.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 16. ISSUE 4-5. P. 441-467 | 164 | 47% | 187 |
10 | MARGRAF, RL , CROCKETT, DK , KRAUTSCHEID, PMF , SEAMONS, R , CALDERON, FRO , WITTWER, CT , MAO, R , (2009) MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 RET PROTOONCOGENE DATABASE: REPOSITORY OF MEN2-ASSOCIATED RET SEQUENCE VARIATION AND REFERENCE FOR GENOTYPE/PHENOTYPE CORRELATIONS.HUMAN MUTATION. VOL. 30. ISSUE 4. P. 548 -556 | 88 | 90% | 38 |
Classes with closest relation at Level 1 |